- Activities: Individualizing the PBC Care Pathway: From Baseline and Beyond , From Long-Term Clinical Evidence to Real-World Data: A MasterClass in Achieving Next-Level HCM Care and Outcomes With Cardiac Myosin Inhibition, Diagnose Early, Communicate Clearly: Optimizing Alzheimer s Outcomes in Primary Care, Restoring Remission in RRMM: Present and Future of Sequential Immunotherapy With GPRC5D Targeting Options, The Second Coming of Finite Therapy in CLL: Making Informed Treatment Decisions With Newer, Time-Limited BTKi Combinations, The Second Coming of Finite Therapy in CLL: Making Informed Treatment Decisions With Newer, Time-Limited BTKi Combinations, Upfront Upgrades for MCL: Integrating the First-line Use of BTKi Platforms to Transform Outcomes Across Patient Populations, Upfront Upgrades for MCL: Integrating the First-line Use of BTKi Platforms to Transform Outcomes Across Patient Populations, Taking a Step Forward in HCM Precision Medicine: Aligning Clinical and Managed Care Approaches With New Guidelines, Long-Term Evidence, and Real-World Experience, Taking a Step Forward in HCM Precision Medicine: Aligning Clinical and Managed Care Approaches With New Guidelines, Long-Term Evidence, and Real-World Experience, Unlocking Efficacy Expanding Access to CAR-T in Lymphoma and Myeloma From Practice-Changing Evidence to Real-World and Outpatient Experiences, Navigating MOGAD: Case-Based Insights into Diagnosis, Treatment, and Management of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Brain Health Essentials: Strategies for Adapting Clinical Practice and Workflows to Optimize Cognitive Functioning in an Aging Population, Brain Health Essentials: Strategies for Adapting Clinical Practice and Workflows to Optimize Cognitive Functioning in an Aging Population, Improving Kidney Transplant Access and Equity With Innovative Immunosuppression Strategies, 2024 ONC US ALK+ Metastatic NSCLC IME ALK+ mNSCLC Care Compass Taking Your Best Shot First: Selecting and Sequencing Targeted Therapy and Teaming-Up to Achieve Long-Term Success, Individualizing Prostate Cancer Management: Employing Evidence-Based Strategies to Impact Community Care Across the Disease Continuum, Illuminating a Better Path Forward for HR+, HER2- MBC: Bridging the Science and Art of Medicine in Clinical Decision-Making, Individualizing Prostate Cancer Management: Employing Evidence-Based Strategies to Impact Community Care Across the Disease Continuum, Spotting the Signs: Mastering the Art of Referring Pediatric Patients with Eosinophilic Esophagitis to Specialty Care for Timely Treatment, Maximizing Impact With the Latest Clinical Evidence: An End-of-Year Review of Novel Therapies for HER2-Positive, HER2-Low, and HER2-Ultralow Breast Cancer, Maximizing Therapeutic Innovations in Bladder Cancer: Expert Strategies for Comprehensive Care Across Disease Stages, Maximizing Therapeutic Innovations in Bladder Cancer: Expert Strategies for Comprehensive Care Across Disease Stages, Establishing the Pillars for Precision Care in Gastric/GEJ Cancer: Expert Guidance on Integrating Molecular Screening and Immunotherapy Platforms Across the Disease Continuum, From Innovation to Implementation: Unlocking the Full Potential of Antibody-Drug Conjugates in Solid Tumors, From Innovation to Implementation: Unlocking the Full Potential of Antibody-Drug Conjugates in Solid Tumors, Targeting PIK3CA/AKT1/PTEN in HR+, HER2- Breast Cancer: Practical Considerations for Personalizing Care, Visualizing the Role of Neuroinflammation in the Pathophysiology and Management of Alzheimer s Disease, The Good, the Bad, and the GVHD: Leveraging Targeted and Cellular Strategies to Improve Access to HCT and Post-transplant Outcomes, Limited-Stage SCLC Amid a Sea Change Brought on by Immunotherapy: How to Make the Most of the New Evidence for Elevating Curative-Intent Treatment Approaches and Upgrading Long-Standing Standards, Illuminating a Better Path Forward for HR+, HER2- MBC: Bridging the Science and Art of Medicine in Clinical Decision-Making, Illuminating a Better Path Forward for HR+, HER2- MBC: Bridging the Science and Art of Medicine in Clinical Decision-Making, A New Era in Treating Advanced Ovarian Cancer Practical Tips for Maximizing the Use of PARP Inhibitors, ADCs, and Other Emerging Targeted Approaches, A New Era in Treating Advanced Ovarian Cancer Practical Tips for Maximizing the Use of PARP Inhibitors, ADCs, and Other Emerging Targeted Approaches, Upfront Upgrades for MCL: Integrating the First-line Use of BTKi Platforms to Transform Outcomes Across Patient Populations, Seeing Beyond Numbers: Empowering Patients in Weight and Glycaemic Management for T2D, Seeing Beyond the Numbers in Type 2 Diabetes: Empowering Patients for Optimal Weight and Glycaemic Management, From Challenges to Changes in R/R CLL: Forging an Academic-Community Practice Alliance for Effective and Safe Sequential Care, From Challenges to Changes in R/R CLL: Forging an Academic-Community Practice Alliance for Effective and Safe Sequential Care, A Collaborative Approach to Identifying Eosinophilic Esophagitis in the ED: Emergency Presentation, Timely Diagnosis, Elevating Excellence in Community Oncology Practice: Pinpointing Challenges and Establishing Success Strategies for Improved Risk Assessment, Treatment Selection, and Adverse Event Management in HR+, HER2- EBC and MBC, Elevating Excellence in HR+, HER2- EBC and MBC Care: Success Strategies for Community Oncology Practice, Elevating Excellence in HR+, HER2- EBC and MBC Care: Success Strategies for Community Oncology Practice, Targeting Higher Standards in Resectable NSCLC: The Surgery-Oncology Coalition for Tailoring Care in EGFR & ALK TKI Therapy, The Innovation Intersection in B-cell Cancers: Navigating Management Choices With Modern Targeted Platforms, Cellular Therapy, and HCT, Individualized Treatment for Generalized Myasthenia Gravis: Targeting the Cause and Prioritizing the Patient, Precision Medicine Crafts a New Story for Metastatic Prostate Cancer: Expert Case Discussion on the Next Act of Intensification Therapies with AKT Inhibition, Precision Medicine Crafts a New Story for Metastatic Prostate Cancer: Expert Case Discussion on the Next Act of Intensification Therapies with AKT Inhibition, From Roots to Results: Elevating Alopecia Areata Management, Biologic Therapy for CRSwNP: Exploring the Advanced Practice Provider's Role in Patient Care, Biologic Therapy for CRSwNP: Exploring the Advanced Practice Provider's Role in Patient Care, Innovative Approaches to Manage Primary Biliary Cholangitis: Charting New Courses of Care, Stories Behind the Science in EGPA: Updated Strategies for Diagnosis, Treatment, and Reducing the Steroid Burden in Patients, Finding The Heat in Cold Tumours: Potential for Perioperative Immunotherapy Strategies in Early Breast Cancer, Mastering the Integration of Immunotherapy in Resectable NSCLC: Practical Considerations for Real-World Practice, What s Around the Corner in Advanced Prostate Cancer? Candid Conversations to Future Proof Your Practice for Targeted Therapies, Advancing Therapeutic Control in Desmoid Tumors Expert Guidance On Modern Diagnostic & Treatment Practices With Gamma Secretase Inhibitors, Accelerating Innovation In Biliary Tract Cancer: Restructuring Treatment Models With Immunotherapy & Targeted Platforms In Advanced Disease, ALL-in on Bispecific Innovation: Guidance on the Present and Future of Off-the-Shelf Immunotherapy in Acute Lymphoblastic Leukemia, ALL-in on Bispecific Innovation: Guidance on the Present and Future of Off-the-Shelf Immunotherapy in Acute Lymphoblastic Leukemia, Strengthening The Immunotherapy Paradigm in Advanced SCAC: Established & Emerging Roles of Immune-Based Platforms Across Lines of Therapy, Retinal Disease in Emergency Medicine: Enhancing Outcomes via Timely Recognition and Referral for Specialty Care, Retinal Disease in Emergency Medicine: Enhancing Outcomes via Timely Recognition and Referral for Specialty Care, Retinal Disease in Emergency Medicine: Enhancing Outcomes via Timely Recognition and Referral for Specialty Care, Exploring New Frontiers in Alzheimer s Disease: Early Detection, Emerging Mechanisms, and Therapeutic Advances, Exploring the Promise of Biomarkers and ATTs in Diagnosing and Treating Early Symptomatic Alzheimer s Disease: Key Takeaways From AD/PD 2025, Understanding the Individual in Front of You: The Importance of Patient Participation in Weight and Glycaemic Management for People With Type 2 Diabetes, A Roadmap for Managing Post-HCT VOD/SOS: Team-Based Guidance on Implementing Modern Approaches to Capturing, Assessing, and Managing Diverse Presentations, A Roadmap for Managing Post-HCT VOD/SOS: Team-Based Guidance on Implementing Modern Approaches to Capturing, Assessing, and Managing Diverse Presentations, Innovation Takes Shape in SCD: Rewriting Management Principles with Gene Therapy & Revisiting the Role of HSCT, Innovation Takes Shape in SCD: Rewriting Management Principles with Gene Therapy & Revisiting the Role of HSCT, The Personalized Paradigm in CRC Care: Translating Emerging Evidence to Guide Therapy Selection in Advanced Disease, Managing Pulmonary Arterial Hypertension in the Era of Novel and Emerging Treatment Options: It Takes a Village, Fortifying the Framework for HER2+ Gastrointestinal Cancers Precision Treatment Planning With Molecularly Targeted Therapies in GC/GEJC, CRC, & BTC, Capitalizing on Personalized Care in IDH-Mutant Gliomas: Expert Guidance on The Use of Biomarker Testing & Targeted Therapies in Real-World Settings, "Experts vs AI" ADC Challenge Lung Cancer Edition: Interpreting the Evidence, Exploring Practicalities, "Experts vs AI" ADC Challenge Lung Cancer Edition: Interpreting the Evidence, Exploring Practicalities, The Future of Care in Postpartum Depression: Comprehensive Strategies for Early Diagnosis and Effective Treatment, Advancing Care in Primary Biliary Cholangitis: The Path Forward, Plugging the Gaps in Hepatitis B and C Care: Understanding and Integrating New Guidelines and Advances in Disease Management, BTK Inhibition as an MS Treatment Strategy: Targeting Smoldering Neuroinflammation, BTK Inhibition in MS: Targeting Smoldering Neuroinflammation, Early Diagnosis and Evolving Management of Eosinophilic Esophagitis in the Era of Targeted Therapy, Resect & Protect Against Melanoma Recurrence: Are you Prepared for the Present and Future of Adjuvant Immunotherapy for Stage II-III Disease?, Refining the First Strike Against EGFR-Mutated Advanced NSCLC: Personalizing Frontline Treatment Decisions Amid Increasing Complexity, Smart Steps for Effective Real-World Care in RCC: Enhancing Outcomes in Advanced Disease, Accelerating Personalized Care in CRC The Prominent Role of Predictive Biomarkers & Immunotherapy Platforms in Early & Advanced Disease, Breaking New Ground in the Treatment of COPD: Exploring the Potential Use of Targeted Biologic Therapy in Patients With Evidence of Type 2 Inflammation, The New Normal: Digital Technologies for People Living With Insulin-Treated Type 2 Diabetes, Navigating Therapeutic Choices in Prostate Cancer: Effective Decision-Making for Patient-Centric Care, Breathing New Life Into Treatment Approaches for COPD: The Latest Insights Into the Role of Type 2 Inflammation and Targeted Biologic Therapy, Staying on Target Against Moderate to Severe Psoriasis: Strategies for Achieving Sustained Benefits Through TYK2 Inhibition, TTRansforming the TTReatment of ATTR: A Guide to the Pathophysiology, Diagnosis, and Emerging Treatment Strategies for ATTR Amyloidosis, Embracing Progress, Transforming Treatment, Empowering Patients: Harnessing the Potential of TROP2-Targeted ADC Therapy in TNBC and HR+, HER2- Breast Cancer, Building Resilient Care Communities of Care in R/R CLL: Collaborative Sequential Approaches in an Era of Innovative Options, Stepping Stones on the Path to a Healthier Future for Patients With Primary Hyperoxaluria Type 1: Expert Perspectives on Ensuring Timely Diagnosis and Appropriate Management, Preparing for a New Script for SCD Care: Guidance on Patient-Centric Treatment Decisions With Innovative Therapeutics, Optimizing Obesity Management Before and After Bariatric Surgery: The Role of Antiobesity Pharmacotherapy to Reduce Weight and Obesity-Related Comorbidities, Intensifying Treatment for Type 2 Diabetes According to Current Guidelines: An Office Hours Activity, Individualizing Management Plans for Type 2 Diabetes Through Shared Decision-Making: An Office Hours Activity, Targeting a New Approach: Understanding the Potential Role of Biologic Therapy in Patients with COPD and Evidence of Type 2 Inflammation, Are We Closer to a Cure with Perioperative Immunotherapy in Early-Stage Resectable NSCLC? Current Conclusions and Ongoing Questions in Clinical Care, Adjusting HIV Treatment for ART-Experienced People With HIV: Switching ART to Address Antiretroviral Resistance, Adverse Events, and Adherence Barriers, Individualizing Management Plans for Type 2 Diabetes Through Shared Decision-Making: An Office Hours Activity, Reinforcing Precision Tactics in Genomically Altered Resectable NSCLC: Collaborative Workflows and Personalized Solutions for Integration of Adjuvant EGFR- and ALK-Targeted Therapies, Prioritizing Weight Management as a Primary Goal in People With Type 2 Diabetes: An Office Hours Activity, Mastering the Art of Myelofibrosis Care: Expert Guidance, Clinical Experience & Innovation for More Personalized Disease Control, Navigating Sequential CLL Care with Modern Therapeutics: Choices & Challenges with BTKi and Cellular Strategies, From Early Detection to Disease Modification: Personalized Approaches to Biomarker Testing and Therapeutic Management of Alzheimer s Disease, Making Precision Decisions in High-Risk HR+, HER2- Metastatic Breast Cancer: Practical Training on Individualizing CDK4/6 Inhibitor Treatment to Enhance Adherence, Quality of Life, and Outcomes, Changing the Future for Families With HoFH: Long-Term Benefits of Early Diagnosis and Treatment for Homozygous Familial Hypercholesterolemia, Taking a BiTE Out of SCLC: Are You Ready for a Wave of DLL3-Targeted T-Cell Engagers?, Using APOE as a Key in Alzheimer s Disease Treatment: Unlocking the Amyloid-Targeting Therapy Risk Benefit Conundrum, Alzheimer s Disease Case Conference: Acquiring New Skills, Visualizing Emerging Strategies for the Era of Amyloid-Targeting Therapies, Innovation in Inflammation: Shaping the IBD Treatment Landscape, Mastering the Art and Science of Biologic Therapy for CRSwNP: Who Are the Candidates and How Do You Manage Their Care?, Mapping a New Treatment Journey in NF1: New Developments With MEKi for Pediatric and Adult Patients With NF1-Plexiform Neurofibromas, Integrating Immunotherapy in Resectable NSCLC: How to Modify Treatment Trajectories and Reorganize Multidisciplinary Care Pathways, Optimizing PARP Inhibitor Therapy in Veterans With Prostate Cancer: A Practical Guide for VA Pharmacists, Keeping PACE in Alzheimer s Disease: Precision Strategies to Achieve Early Diagnosis and Safely Integrate Disease-Modifying Treatment, Experts vs AI Challenge: Diagnosing and Managing Nontuberculous Mycobacterial Lung Disease, Uncovering the Role of Epithelial Cytokines in CRSwNP: Examining the Clinical Implications of New Approaches with Targeted Biologic Therapy, In Pursuit of a Functional Cure for Hepatitis B: Monitoring Effectively, Optimizing Treatment, and Reducing Risk of Complications, Critically Focusing Decision-Making and Communication Strategies to Reduce Recurrence in High-Risk HR+, HER2- EBC: Modeling Best Practices for Assessing Risk, Selecting Patients for Adjuvant CDK4/6i Therapy, and Fostering Treatment Adherence/Persistence, Advancing Immunotherapy: Revolutionizing Cervical Cancer Treatment, Lipid Management Beyond Statins: Early Screening, Prompt Intervention, and Timely Intensification With PCSK9-Targeted Therapies, A Modern Take on a Classic: Overcoming Today's Hepatitis Immunization Hurdles with Recent Guidelines and Practical Strategies, Rethinking and Refining Endometrial Cancer Care in the Modern Age of Precision Medicine: How to Translate Clinical Evidence Into Meaningful Improvements for Patients, Conversations With Peers About T2DM: Best Practices for Optimizing Treatment Using Weight Management as a Primary Goal, Emerging Options for Targeting PCSK9 in Hypercholesterolemia Management: Visualizing New Routes to Individualized Care, Preparing Specialists for the New Era in Alzheimer s Disease: A Case-Based Exploration of Strategies for Integrating Diagnostic Biomarkers and Amyloid-Targeting Therapies Into Practice, Building The Alliance in Dedifferentiated Liposarcoma: Integrating Personalized, Multidisciplinary Care With Innovative MDM2 Antagonists in Advanced Disease, Renovating Frontline Care for Metastatic Melanoma: Expert Guidance on Upgrading to Combination Immunotherapy Standards Across Disease Presentations, The Burden of RSV in Pediatric Populations: Evidence for Reshaping Care and Optimizing Prophylaxis, Transforming T2DM Treatment in Primary Care: Discerning the Glycemic and Extra-Glycemic Effects of GLP-1 RAs, Don t Fail Them Now: Bridging the Gaps in the Diagnosis and Treatment in Transthyretin Cardiac Amyloidosis, Exchanging Ideas on How to Navigate Patient-Centric Clinical Decisions in Integration of TROP2-Targeted Therapy in TNBC and HR+, HER2- Breast Cancer, Elevating Expectations, Broadening Impact: How to Leverage Immunotherapy and EGFR-Targeted Therapy to Improve Outcomes in Unresectable Stage III NSCLC, Prioritising Patient-Centric Care in Biliary Tract Cancer: Leveraging Immunotherapy Platforms to Overcome Challenges in The Advanced Setting, Crafting Custom Care in CLL: Guidance on Upfront and Sequential Treatment Decisions With Targeted and Immune-based Platforms, TTRemendous Advances in Transthyretin Amyloidosis Treatment: What Neurologists Need to Know, Breaking Through Biases: Collaborative Weight Management in Primary Care and Treating Obesity as a Chronic Disease, Clotting the Gaps in VWD Care: Elevating Diagnostic Awareness and Treatment Planning With Modern Therapeutic Approaches, Mastering Diagnosis and Navigating the Sea of Targeted Treatments in NMOSD: Practical Guidance on Optimizing Patient Care, How to Make Multifactorial Clinical Decisions in HR+, HER2- EBC and MBC: Guiding Precision Amid Growing Complexity, Experts vs AI: Exploring New Paradigms in Comprehensive Cardio-Renal-Metabolic Care, Leveraging the Power of Targeted Biologic Therapy in Severe Asthma: Do You Know How and For Whom?, Illuminating the Path With Immunotherapy for Metastatic, Locally Advanced, and Early-Stage NSCLC: A Guide to Patient Assessment, Treatment Selection, and Multidisciplinary Collaboration Across the Disease Continuum, Precision Learning for Precision Medicine: What You Need to Know About Hitting the Type 2 Target With Biologic Treatment for CRSwNP, All Things Considered in Psoriasis Management: Looking at the Role of Biologic Therapies in a Holistic Approach, On Target: Integrating Trop-2-directed Therapeutics for Urothelial Carcinoma with Precision, Improving Outcomes for Pediatric Patients With Uncontrolled Moderate to Severe Asthma Using a Collaborative Approach: Recognition, Referral, and Management in the Era of Targeted Treatment Options, A Roadmap for Modern RCC Care: Navigating Personalized Treatment Selection and Sequencing, Navigating Recent Advances in Endometrial Carcinoma Treatment: Expert Guidance to Unleash the Power of Immunotherapy and other Emerging Therapeutic Regimens, Mastering Multidirectional Tactics in HCC: Expert Guidance on Emerging Trends With Systemic Therapy Options Across the Disease Continuum, The Itch We Could Never Scratch: Incorporating New and Emerging Therapies to Alleviate the Burden of Prurigo Nodularis With a Team-Based Approach, Four-Ward Progress in NDMM: New Developments With CD38 Antibody Quadruplets, Rising to the Challenges of Early and Advanced H + Breast Cancer Parsing Complex Evidence to Clarify Clinical Decisions, Achieving Optimal SCLC Care With Established and Innovative Therapies: Latest Evidence, Key Ongoing Trials, and Practical Considerations for Real-World Practice, Remodeling Innovation: Applying Clinical Research and Real-World Experience With Cardiac Myosin Inhibition in HCM & Beyond, Updating the Lung Cancer Treatment Algorithms With Novel Antibody-Drug Conjugates: Are You Prepared for Change? State of the Science, Implications for Practice, and Future Prospects, Decoding Biomarker Testing and Targeted Therapy in NSCLC: The Complete Guide for 2024, Adapting HIV Treatment for People With Substance Use Disorder, On Target: Understanding the Impact of PSMA for Diagnostic and Therapeutic Strategies in Prostate Cancer, CONTROL Myelofibrosis: Current Options, New Treatment Principles, and Opportunities to Leverage JAKi Platforms and Novel MOAs, A Pharmacist s Take on Navigating the Expanding Therapeutic Landscape for Endometrial and Cervical Cancers: Insights on Coordinating and Delivering Effective Modern Care, Striking Back at ALL: Achieving Lasting Benefits with Bispecific Antibodies & MRD-Guided Strategies Across Disease Settings, Modern Team-Based Therapeutic Management for Bladder Cancer Care - Expert Strategies for Integrating the Latest Evidence and Treatment Advances, Progress Meets Innovation in HNC Management: Perspectives on Immunotherapy, Emerging Modalities, and Novel Agents Across Disease Settings, Extending Innovation From Lymphoma to Myeloma: Catching the Next Wave of Bispecific Antibody Breakthroughs for Clinical Care, The Three Rs of Modern Myeloma Care: Using Antibody and BCMA Platforms to Deliver the Right Treatment for the Right Patient at the Right Time, Establishing the Collaborative Benchmark for HCC Care: Critical Discussions Between Interventional Radiologists and Oncologists to Maximize Therapeutic Benefit, Unlocking the Power of Modern Therapeutic Regimens for Prostate Cancer: Experts Put the Pressure on Key Evidence and Real-World Strategies to Optimize Patient Care, Navigating Rapid Changes in First- and Later-Line Treatment of EGFR-Mutated NSCLC: A Practical Framework for Optimal Biomarker Testing, Treatment Selection and Sequencing, and Adverse Event Management, Charting a New Path to Better Outcomes With TROP2-Targeting ADCs in Lung Cancer: Unveiling Potential, Shaping Tomorrow, Unleashing the Innovation Era in AML Care: Guidance for the Community on Practice Principles & Precision Medicine with Innovative Therapeutics, Specialty Training for the New Era in Alzheimer s Disease: Building Skills for Making an Early Diagnosis and Implementing Disease-Modifying Treatment, Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Implementing Modern Therapeutic Advances Across the Disease Continuum, Treatment Advances and Individualized Therapeutic Strategies in Prostate Cancer: Expert Insights on Key Evidence, Practical Tips for Personalized Therapy, and Clinical Integration Approaches, Accelerating Therapeutic Progress in HER2+ and HER2-Low Breast Cancer: State of the Science and Guidance for Individualized Clinical Decisions, Maximizing the Role of ADCs in Urothelial Carcinoma Treatment Practical Tips for Patient Selection, Safety Management, and Collaborative Care, Screening and Early Intervention as the Keys to Success in Lung Cancer: A Practical Approach to Implementing Lung Cancer Screening for High-Risk Individuals, Biologics in CRSwNP: Putting a Paradigm Shift Into Practice, From Resistance to Resilience in R/R CLL: Sequencing Strategies for Achieving Effective Continuous Care, Navigating Advances in Alzheimer s Disease: An Expert Consult on Integrating the New Diagnostic Tools and Disease Modifying Therapies Into Your Clinical Practice, Precision Tactics in HER2-Positive GI Malignancies Capitalizing on HER2-Targeted Regimens to Improve Outcomes for G/GEJ Cancers, CRC, and BTC, Navigating Narcolepsy in Family Practice: Patient-Centered Strategies to Optimize the Experience and Outcomes of Treatment, A Joint Effort for Equitable Hemophilia A Care: Collaborative Solutions for Enhancing Outcomes in Diverse and Challenging Patient Populations, Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies, Adapting Managed Care Strategies in the Era of Precision Medicine for Hypertrophic Cardiomyopathy, Taking the Front Seat in Metastatic Melanoma Care: Guidance on Using PD-1/LAG-3 Platforms as Modern First-Line Options, Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders and the Rationale for Targeted Biologic Therapy: Focus on Moderate to Severe Atopic Dermatitis, Prurigo Nodularis, Chronic Urticaria, and Bullous Pemphigoid, REVIVE Initiative: Reinforcing Evidence-based Principles Against Cancer-Associated Venous Thromboembolism, Catalysts for Change in SCLC: Optimizing the Use of Standard Therapies and Accelerating the Transition of Emerging Strategies to the Clinic, A Clinical Compass for Selecting and Sequencing HER2-Targeting Therapies in HER2-Positive Metastatic Breast Cancer: An Update on the Latest Evidence, Guidelines, and Expert Insights, Making Precision Decisions in the Treatment of NSCLC With Common and Uncommon EGFR Mutations: How to Navigate the Expanding Options and Increasing Complexity, Ten Steps for Highly Successful Myeloma Care: Guidance on the Road to Remission With Antibodies, BCMA Immunotherapy, and Other Innovations, Addressing Unmet Patient Needs in Bullous Pemphigoid: Exploring Targeted Treatment for Safe and Effective Care, New Chapters in the Immunotherapy Story for Resectable Melanoma: Collaborative Care and Next-Steps With Adjuvant and Neoadjuvant Therapy, Simplifying the Complicated: An Algorithmic Guide for Clinical Decision- Making in High-Risk HR+, HER2- EBC and MBC, Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices for Patient Education, irAE Management, and Survivorship Care, Advancing ADCs in Gynecologic Cancers: Expert Insights on Recent Evidence, Implementation Strategies, and Practical Tips for Patient Care, Synergizing For Success in HCC: Immunotherapy Advances and the Role of the Interventional Radiologist - Oncologist Collaboration Across the Disease Continuum, From Resistance to Resilience in R/R CLL: Sequencing Strategies for Achieving Effective Continuous Care, Adapting Our Strategies for Decision-Making in Testing and Treatment of RET-Altered Lung and Thyroid Cancers: A Personalized Learning Journey, Empowering Providers & Patients to Battle Advanced Biliary Tract Cancers: Expert Guidance on Integrating the Latest Evidence on Immunotherapy & Targeted Agents in Real-World Practice, Advancing Personalized Care in RCC: Navigating Rapid Therapeutic Expansion and Sequencing Strategies, Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care Strategies, Custom Care Compass: Mastering Multifactorial Clinical Decision Making in High-Risk HR+, HER2- MBC, Calibrating Care Across the HCC Continuum: Guidance on Delivering Effective Care with Modern Immunotherapy and Targeted Approaches, Peer Pressure: How Well Do You Know Your ADCs? Cracking the Code of Targeted Delivery of Cytotoxic Payloads in Lung Cancer, Making an Impact in Bladder Cancer Care: Integrating the Latest Evidence and Modern Therapeutic Advances Across the Disease Continuum, Building a Better Bridge: Providing Continuous SMA Care From Adolescence Through Adulthood
- Provider Ship: 1
- Provider Address: New York, NY, USA
- Activity Link: www.peerview.com
- Number of Activities Reported Last Year: 511
- Name of Contact: Cyndi Grimes
- Phone Number: (973) 727-1974
- Address: 174 W 4th Street, Ste 182, New York, NY, 10014, USA
- Accreditation Status: Joint Accreditation with Commendation
- Accredited Provider: Joint Accreditation
- Activity Format: Enduring Material, Live Course
Deprecated: File Theme without comments.php is deprecated since version 3.0.0 with no alternative available. Please include a comments.php template in your theme. in /nas/content/live/sleepliteracy/wp-includes/functions.php on line 6121
Leave a Reply